Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.

Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and per...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melissa Starkey, Francois Lepine, Damien Maura, Arunava Bandyopadhaya, Biljana Lesic, Jianxin He, Tomoe Kitao, Valeria Righi, Sylvain Milot, Aria Tzika, Laurence Rahme
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Acceso en línea:https://doaj.org/article/9aa02961081547b7bbda3bdbbafe6365
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9aa02961081547b7bbda3bdbbafe6365
record_format dspace
spelling oai:doaj.org-article:9aa02961081547b7bbda3bdbbafe63652021-11-25T05:46:09ZIdentification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.1553-73661553-737410.1371/journal.ppat.1004321https://doaj.org/article/9aa02961081547b7bbda3bdbbafe63652014-08-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25144274/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and persistent human infections. Here, we target the MvfR-regulated P. aeruginosa quorum sensing (QS) virulence pathway to isolate robust molecules that specifically inhibit infection without affecting bacterial growth or viability to mitigate selective resistance. Using a whole-cell high-throughput screen (HTS) and structure-activity relationship (SAR) analysis, we identify compounds that block the synthesis of both pro-persistence and pro-acute MvfR-dependent signaling molecules. These compounds, which share a benzamide-benzimidazole backbone and are unrelated to previous MvfR-regulon inhibitors, bind the global virulence QS transcriptional regulator, MvfR (PqsR); inhibit the MvfR regulon in multi-drug resistant isolates; are active against P. aeruginosa acute and persistent murine infections; and do not perturb bacterial growth. In addition, they are the first compounds identified to reduce the formation of antibiotic-tolerant persister cells. As such, these molecules provide for the development of next-generation clinical therapeutics to more effectively treat refractory and deleterious bacterial-human infections.Melissa StarkeyFrancois LepineDamien MauraArunava BandyopadhayaBiljana LesicJianxin HeTomoe KitaoValeria RighiSylvain MilotAria TzikaLaurence RahmePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 8, p e1004321 (2014)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Melissa Starkey
Francois Lepine
Damien Maura
Arunava Bandyopadhaya
Biljana Lesic
Jianxin He
Tomoe Kitao
Valeria Righi
Sylvain Milot
Aria Tzika
Laurence Rahme
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
description Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and persistent human infections. Here, we target the MvfR-regulated P. aeruginosa quorum sensing (QS) virulence pathway to isolate robust molecules that specifically inhibit infection without affecting bacterial growth or viability to mitigate selective resistance. Using a whole-cell high-throughput screen (HTS) and structure-activity relationship (SAR) analysis, we identify compounds that block the synthesis of both pro-persistence and pro-acute MvfR-dependent signaling molecules. These compounds, which share a benzamide-benzimidazole backbone and are unrelated to previous MvfR-regulon inhibitors, bind the global virulence QS transcriptional regulator, MvfR (PqsR); inhibit the MvfR regulon in multi-drug resistant isolates; are active against P. aeruginosa acute and persistent murine infections; and do not perturb bacterial growth. In addition, they are the first compounds identified to reduce the formation of antibiotic-tolerant persister cells. As such, these molecules provide for the development of next-generation clinical therapeutics to more effectively treat refractory and deleterious bacterial-human infections.
format article
author Melissa Starkey
Francois Lepine
Damien Maura
Arunava Bandyopadhaya
Biljana Lesic
Jianxin He
Tomoe Kitao
Valeria Righi
Sylvain Milot
Aria Tzika
Laurence Rahme
author_facet Melissa Starkey
Francois Lepine
Damien Maura
Arunava Bandyopadhaya
Biljana Lesic
Jianxin He
Tomoe Kitao
Valeria Righi
Sylvain Milot
Aria Tzika
Laurence Rahme
author_sort Melissa Starkey
title Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
title_short Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
title_full Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
title_fullStr Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
title_full_unstemmed Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
title_sort identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/9aa02961081547b7bbda3bdbbafe6365
work_keys_str_mv AT melissastarkey identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT francoislepine identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT damienmaura identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT arunavabandyopadhaya identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT biljanalesic identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT jianxinhe identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT tomoekitao identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT valeriarighi identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT sylvainmilot identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT ariatzika identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
AT laurencerahme identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity
_version_ 1718414473108127744